Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
PROPOFOL
Cyton Biosciences Ltd
QN01AX10
PROPOFOL
10 Mg/Ml
Emulsion for Injection
VPO-Vet.Practitioner Only
Canine, Feline
Propofol
Anaesthetic/Analgesic
Authorised
2017-03-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Proposure 10 mg/ml emulsion for injection for dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Propofol 10 mg EXCIPIENTS: For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Emulsion for injection. White or almost white, homogenous emulsion. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES A short-acting, intravenous general anaesthetic with a short recovery period. Intended for brief procedures lasting up to five minutes. For induction and maintenance of general anaesthesia by administration of incremental doses to effect. For induction of general anaesthesia, where maintenance is provided by inhalation anaesthetic agents. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The product is a stable emulsion. Prior to use, the product should be inspected visually for absence of visible droplets or extraneous foreign particles or phase separation and discarded if present. If the product is injected too slowly an adequate plane of anaesthesia may not be achieved due to failure to reach the appropriate threshold of pharmacological activity. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _1_ _/_ _0_ _3_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _2_ _8_ _8_ _1 Read the complete document